Wednesday, 22 October 2014
Last updated 12 hours ago
Aug 16 2013 | 1:18am ET
Activist hedge fund Trian Fund Management has amassed a huge stake in chemical giant DuPont Co. and has already begun pushing for changes.
Trian, led by Nelson Peltz, has bought a 2.2% stake in DuPont worth $1.3 billion. And Peltz has wasted no time, having already met with DuPont CEO Ellen Kullman and other senior executives.
According to the Wilmington News-Journal, Peltz presented DuPont with one of his famous white papers, suggesting how to boost shareholder value and improve long-term growth prospects.
"We will evaluate any ideas Trian may have in the context of our ongoing initiatives to build a higher value, higher growth company for our shareholders," DuPont spokesman Michael Hanretta said.
DuPont this week adopted several poison pills, including provisions that would pay executives larger severance and changing the way that board candidates are nominated.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Sep 30 2014 | 9:29am ET
The crisp Autumnal days of October are upon us, and so are a few of the hedge fund industry’s favorite charitable events. If you have never been to Rocktoberfest, well, you are missing out. And for a quieter evening of sipping and socializing, stop by HFC’s Wine Soiree. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...